- cafead   Jul 02, 2024 at 03:13: PM
via The U.S. Food and Drug Administration on Tuesday approved Eli Lilly's (LLY.N) treatment for early Alzheimer's, making it the second therapy for slowing progression of the brain-wasting disease that will be available to U.S. patients.
article source
article source